In recipients of a third BMT, mild CML-like disease developed within one month, but Foxo3a deficiency prevented the propagation of CML cells in the peripheral blood and spleen. The gene discussed is FOXO3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.